Feature | SCAI | February 25, 2019 | Subhash Banerjee, M.D., FSCAI, Abu-Fadel Mazen, M.D., FSCAI and Rajesh Swaminathan, M.D., FSCAI

Peripheral Vascular Track Highlighted at SCAI 2019

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. Henry Ford Hospital CTO case.

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. 

The track will include a blend of clinical challenges presented by emerging interventional stars and approaches to addressing them, which will be articulated and critiqued by expert panelists. The audience will be able to participate in discussion and share their expertise and experience. The program was changed from last year to move away from global overviews toward highly specific topics that will capture the burning issues in peripheral artery disease (PAD)

Peripheral live cases will offer an opportunity to see some of the most technically refined and engaging operators demonstrate their approach to complex endovascular cases. A professionally produced broadcast will highlight each movement and device manipulation, with commentary from a group of expert panelists. 

The track also includes multiple technically enriching sessions with a mix of "do’s and don’ts," as well as ways to bail out of trouble, end of the road options, and “my worst nightmare.” Designed to foster candid discussions on the execution of specific technical maneuvers and ways to improvise out of the box solutions, these sessions will provide an opportunity to engage colleagues over the details of technical execution and device selection. 

The exhibit hall technology exhibits will offer several hands-on displays so attendees can try wires and devices. Cases over cocktails in the exhibit hall will offer immersed learning, providing an opportunity to share informal commentary, friendly critique and candid self-assessment of skills and abilities. 

The goal track will take a step beyond minimally invasive arterial interventions. These sessions have been designed to carefully choreographed synergy between devices and medical interventions as the cornerstone for delivering effective and durable therapy to patients. This concept will be front and center during highly practical didactic sessions on polyvascular disease states, pulmonary embolism, stroke interventions, venous diseases, thrombophilia, antithrombotic drug therapies and more.

Finally, the SCAI 2019 Peripheral Vascular Track has made it a priority to showcase many talented and emerging new presenters from diverse backgrounds and specialties, whose accomplishments vastly surpass their youth and experience. 

For more information: http://www.scai.org/scai2019

 

Editor's note: The authors are the program directors for the peripheral vascular track at SCAI 2019. They include: 

Subhash Banerjee, M.D., FSCAI, is a professor of medicine at the University of Texas Southwestern Medical Center (UTSW) and also is the chief of cardiology at the VA North Texas Health Care System in Dallas.

Abu-Fadel Mazen, M.D., FSCAI, is director of interventional cardiology and cardiac cath lab at the University of Oklahoma Health Sciences Center.

Rajesh Swaminathan, M.D., FSCAI, is an associate professor of medicine at Duke University School of Medicine. 


Related Content

News | SCAI

May 3, 2025 — The Society for Cardiovascular Angiography & Interventions (SCAI) announced its new leadership for 2025–26 ...

Home May 05, 2025
Home
News | SCAI

At the SCAI 2025 Scientific Sessions in Washington, DC, SCAI President James B. Hermiller, MD, MSCAI, recognized several ...

Home May 01, 2025
Home
News | SCAI

Feb. 12, 2025 — A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type ...

Home February 18, 2025
Home
News | SCAI

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

Home May 07, 2024
Home
News | SCAI

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...

Home May 07, 2024
Home
News | SCAI

May 1, 2024 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific ...

Home May 01, 2024
Home
News | SCAI

June 1, 2023 — New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor ...

Home June 01, 2023
Home
News | SCAI

May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal ...

Home May 24, 2023
Home
Feature | SCAI | Christine Book

May 23, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) welcomed its 46th President and 2023 ...

Home May 23, 2023
Home
News | SCAI

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

Home May 19, 2023
Home
Subscribe Now